A second factor XA inhibitor (novel oral anticoagulant, NOAC), after rivaroxaban, has been approved for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). Apixaban is marketed by Bristol-Myers Squibb and Pfizer as Eliquis.
New guidelines provide a simple response to occupational exposure to HIV: Take three anti-retrovirals as soon as possible and re-evaluate after 72 hours.
Imagine having to tell a neurosurgery patient that as a result of their recent procedure they may have been exposed via contaminated surgical instruments to the exceedingly rare but legitimately real risk of transmission of Creutzfeldt-Jakob Disease (CJD).
A recently published MRSA study showing a universal decolonization approach is more effective than active detection and isolation (ADI) has prompted critical questions from proponents of ADI.
Osteoarthritis (OA) can be described as the failed repair of damage that has been caused by excessive mechanical stress (defined as force/unit area) on joint tissues.1 This implies that although multiple factors may lead to OA, mechanical impact (either as a major single event or as repetitive micro trauma) is central to all of these, and that the sequence of events that ensues represents the intrinsic repair process, which may either fail or be successful in restoring joint function. Also known as osteoarthrosis or degenerative joint disease, OA is the most important chronic musculoskeletal disorder in both humans and horses.
